Based in France, Egle Therapeutics is a startup.
Egle Therapeutics develops precision medicines that modulate regulatory T cells to treat autoimmune diseases and cancer by selectively inhibiting or expanding Tregs to rebalance immune function.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.